Mutual Fund Ownership
Ownership as on: Tue, 23 Apr, 2024

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)20.58
% of AUM2.57%

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)104.18
% of AUM1.46%

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

NA
Equity
Amount Invested (Cr.)45.14
% of AUM1.20%

ICICI Prudential Innovation Fund Regular Growth

NA
Equity
Amount Invested (Cr.)27.91
% of AUM0.63%

Nippon India Retirement Fund - Wealth Creation Scheme - Regular Growth

NA
Solutions Oriented
Amount Invested (Cr.)19.00
% of AUM0.63%

FAQs about Thyrocare Technologies share price

Thyrocare Technologies is trading at 644.60 as on Tue Apr 23 2024 09:59:06. This is -0.05% lower as compared to its previous closing price of 644.95.

The market capitalization of Thyrocare Technologies is 3413.31 Cr as on Tue Apr 23 2024 09:59:06.

The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0 analysts have given a buy rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Thyrocare Technologies is 722.00 whereas the 52 wk low is 432.05

Thyrocare Technologies can be analyzed on the following key metrics -

  • TTM P/E: 52.49
  • Sector P/E: 28.84
  • Dividend Yield: 0.00%
  • D/E ratio: -

Thyrocare Technologies reported a net profit of 64.49 Cr in 2023.

Recommended For You
Trending Stocks
1,342.30+43.85(3.38%)
2,502.75+43.60(1.77%)
12,974.35+195.65(1.53%)
2,918.50-42.10 (-1.42%)
HomeMarketsPremiumFor youGet App